Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Cronos Australia Ltd. ( (AU:VIT) ).
Vitura Health Limited has completed the acquisition of Candor Medical, a provider of innovative prescription treatments including medicinal cannabis through telehealth consultations. This acquisition, supported by a $5.17 million placement, aims to enhance Vitura’s service offerings and drive growth. By integrating Candor Medical into its operations, Vitura strengthens its position in the digital health sector, expanding its reach and capabilities in delivering healthcare solutions. The acquisition is expected to add significant value to shareholders and enhance service delivery to its growing patient base.
More about Cronos Australia Ltd.
Vitura Health Limited is a diversified digital health business listed on the ASX, primarily focused on the sale and distribution of medicinal cannabis products through its Canview platform. It also operates a telehealth platform, Doctors on Demand, providing primary health solutions, and has a joint venture to supply psychedelics for research and therapeutic use. Vitura is equipped to distribute a wide range of products from its distribution centers in Melbourne and the Gold Coast, aiming to integrate various healthcare services into its digital platform.
YTD Price Performance: 50.0%
Average Trading Volume: 400,935
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$78.78M
For a thorough assessment of VIT stock, go to TipRanks’ Stock Analysis page.
